Psychiatr Serv 52:1242-1244, September 2001
© 2001 American Psychiatric Association
Delays in Adopting Evidence-Based Dosages of Conventional Antipsychotics
Marcia Valenstein, M.D., M.S.,
Laurel Copeland, M.P.H.,
Richard Owen, M.D.,
Fred Blow, Ph.D. and
Stephanie Visnic, M.S.
By the 1980s, strong research evidence had emerged supporting the use of moderate doses of conventional antipsychotics—between 300 and 1,000 mg of chlorpromazine equivalent daily. We conducted a cross-sectional study of dosages of antipsychotics prescribed for 936 veterans with schizophrenia in 14 facilities between 1991 and 1995. Only 52 percent of these patients received prescriptions for recommended dosages; dosages were below the recommended range for 20 percent and above the range for 28 percent. African Americans were more likely than others to have received high dosages. These data suggest that there was considerable delay in the adoption of evidence-based dosing of conventional antipsychotics. Efforts must be made to transfer research findings more rapidly into practice.
This article has been cited by other articles:
|
|
|
|
 
L. B Dunn, P. J Candilis, and L. W. Roberts
Emerging Empirical Evidence on the Ethics of Schizophrenia Research
Schizophr Bull,
January 1, 2006;
32(1):
47 - 68.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Fleishman
Clinical Experience and Prescribing Practices
Psychiatr Serv,
May 1, 2002;
53(5):
631 - 632.
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 2001
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
